95 related articles for article (PubMed ID: 20856125)
1. Dual-energy computed tomography to assess tumor response to hepatic radiofrequency ablation: potential diagnostic value of virtual noncontrast images and iodine maps.
Lee SH; Lee JM; Kim KW; Klotz E; Kim SH; Lee JY; Han JK; Choi BI
Invest Radiol; 2011 Feb; 46(2):77-84. PubMed ID: 20856125
[TBL] [Abstract][Full Text] [Related]
2. Dual-energy CT in assessing therapeutic response to radiofrequency ablation of renal cell carcinomas.
Park SY; Kim CK; Park BK
Eur J Radiol; 2014 Feb; 83(2):e73-9. PubMed ID: 24345460
[TBL] [Abstract][Full Text] [Related]
3. Radiofrequency ablation of unresectable liver tumors: factors associated with incomplete ablation or local recurrence.
Ayav A; Germain A; Marchal F; Tierris I; Laurent V; Bazin C; Yuan Y; Robert L; Brunaud L; Bresler L
Am J Surg; 2010 Oct; 200(4):435-9. PubMed ID: 20409524
[TBL] [Abstract][Full Text] [Related]
4. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation for unresectable tumors of the liver.
Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
[TBL] [Abstract][Full Text] [Related]
7. Preoperative RFA simulation for liver cancer using a CT virtual ultrasound system.
Kudo K; Moriyasu F; Mine Y; Miyata Y; Sugimoto K; Metoki R; Kamamoto H; Suzuki S; Shimizu M; Miyahara T; Yokoi M; Horibe T; Yamagata H
Eur J Radiol; 2007 Feb; 61(2):324-31. PubMed ID: 17049791
[TBL] [Abstract][Full Text] [Related]
8. Image fusion as a new postprocessing method to evaluate the radiofrequency ablation zone after treatment of malignant liver tumors.
Iyer RS; Timm BA; Mitsumori LM; Kolokythas O
J Comput Assist Tomogr; 2010; 34(2):226-8. PubMed ID: 20351510
[TBL] [Abstract][Full Text] [Related]
9. [Percutaneous radiologic thermocoagulation treatment of liver, kidney and lung tumours].
Kroft LJ; van der Linden E; Obermann WR
Ned Tijdschr Geneeskd; 2005 Jun; 149(26):1448-53. PubMed ID: 16010955
[TBL] [Abstract][Full Text] [Related]
10. [Radiofrequency ablation of malignant liver tumors: use of a volumetric necrosis-tumor ratio for local control].
Kühl H; Stattaus J; Kühl B; Boes T; Antoch G; Frilling A; Forsting M
Rofo; 2006 Dec; 178(12):1243-9. PubMed ID: 17136648
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
Kim HO; Kim SK; Son BH; Yoo CH; Hong HP; Cho YK; Kim BI
Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075
[TBL] [Abstract][Full Text] [Related]
12. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy.
Elias D; De Baere T; Smayra T; Ouellet JF; Roche A; Lasser P
Br J Surg; 2002 Jun; 89(6):752-6. PubMed ID: 12027986
[TBL] [Abstract][Full Text] [Related]
14. Impact of whole-body imaging on treatment decision to radio-frequency ablation in patients with malignant liver tumors: comparison of [18F]fluorodeoxyglucose-PET/computed tomography, PET and computed tomography.
Kuehl H; Rosenbaum-Krumme S; Veit-Haibach P; Stergar H; Forsting M; Bockisch A; Antoch G
Nucl Med Commun; 2008 Jul; 29(7):599-606. PubMed ID: 18528181
[TBL] [Abstract][Full Text] [Related]
15. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
[TBL] [Abstract][Full Text] [Related]
16. Patient factors affecting thermal lesion size with an impedance-based radiofrequency ablation system.
Glaiberman CB; Pilgram TK; Brown DB
J Vasc Interv Radiol; 2005 Oct; 16(10):1341-8. PubMed ID: 16221905
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablation for hepatocellular carcinoma: assistant techniques for difficult cases.
Inoue T; Minami Y; Chung H; Hayaishi S; Ueda T; Tatsumi C; Takita M; Kitai S; Hatanaka K; Ishikawa E; Yada N; Hagiwara S; Ueshima K; Kudo M
Oncology; 2010 Jul; 78 Suppl 1():94-101. PubMed ID: 20616590
[TBL] [Abstract][Full Text] [Related]
18. [CT-guided radiofrequency ablation of liver metastases from colorectal cancer].
Mahnken AH; Bruners P; Tacke JA; Günther RW
Dtsch Med Wochenschr; 2009 May; 134(19):976-80. PubMed ID: 19401962
[TBL] [Abstract][Full Text] [Related]
19. Transthoracic percutaneous radiofrequency ablation for liver tumors in the hepatic dome.
Shibata T; Shibata T; Maetani Y; Kubo T; Itoh K; Togashi K; Hiraoka M
J Vasc Interv Radiol; 2004 Nov; 15(11):1323-7. PubMed ID: 15525754
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of hepatic radiofrequency ablation in patients with bilioenteric anastomoses.
Eisele RM; Veltzke-Schlieker W; Gebauer B; Denecke T; Chopra SS
Hepatogastroenterology; 2010; 57(104):1499-504. PubMed ID: 21443110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
